At a glance
- Originator Unknown
- Class Antiarrhythmics
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 17 Nov 2003 Discontinued for Arrhythmias (unspecified route)
- 14 Oct 1994 No-Development-Reported for Arrhythmias (Unknown route)